Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2002, Volume 26, Issue 4

The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-04-02-2002
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
Annex 1 Alignment: Addressing Contamination Control and Assessing Risk
Charles River to Provide pDNA Manufacturing Services in Two Deals